Literature DB >> 10470923

Using urokinase to treat malignant pleural effusions.

R C Gilkeson1, P Silverman, J R Haaga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470923     DOI: 10.2214/ajr.173.3.10470923

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  6 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study.

Authors:  Ozkan Saydam; Kemal Karapinar; Mertol Gokce; Lutfiye Kilic; Muzaffer Metin; Ibrahim Ilker Oz; Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2015-05-10       Impact factor: 3.064

Review 3.  Pleural effusion.

Authors:  A R Medford; A Medford; N Maskell
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

Review 4.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08

5.  Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.

Authors:  Li-Han Hsu; Pei-Chi Hsu; Tien-Ling Liao; An-Chen Feng; Nei-Min Chu; Shu-Huei Kao
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

Review 6.  Management of Septated Malignant Pleural Effusions.

Authors:  Radhika Banka; Dayle Terrington; Eleanor K Mishra
Journal:  Curr Pulmonol Rep       Date:  2018-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.